| Dr Dina Robin Gabaeff, MD | |
|
2020 Palomino Lane, #100, Las Vegas, NV 89106-4894 | |
| (702) 759-8600 | |
| (702) 384-1815 |
| Full Name | Dr Dina Robin Gabaeff |
|---|---|
| Gender | Female |
| Speciality | Diagnostic Radiology |
| Experience | 32 Years |
| Location | 2020 Palomino Lane, Las Vegas, Nevada |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1538127568 | NPI | - | NPPES |
| 1538127568 | Medicaid | CA | |
| AZ0324990 | Other | AZ | BCBS |
| 378035 | Other | AZ | AHCCCS |
| P01190313 | Other | NV | RR MEDICARE DESERT RADIOLOGY SOLUTIONS LLC |
| P01197941 | Other | NV | RR MEDICARE |
| 1Z7049 | Other | AZ | HEALTHNET |
| Facility Name | Location | Facility Type |
|---|---|---|
| Summerlin Hospital Medical Center | Las vegas, NV | Hospital |
| Henderson Hospital | Henderson, NV | Hospital |
| Centennial Hills Hospital Medical Center | Las vegas, NV | Hospital |
| Spring Valley Hospital Medical Center | Las vegas, NV | Hospital |
| Valley Hospital Medical Center | Las vegas, NV | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Ellis Bandt Birkin Kollins And Wong Pllc | 4486568946 | 108 |
| Shelin Agrawal And Hyer Pllc | 5890955959 | 94 |
News Archive
Teva Pharmaceutical Industries Ltd. and Active Biotech today presented data further illuminating the novel, dual mechanism of action (MOA) of investigational oral, once-daily, laquinimod for the treatment of relapsing-remitting multiple sclerosis (RRMS), conferring neuroprotective and anti-inflammatory properties.
Stem cells extracted from body fat may pave the way for the development of new regenerative therapies including soft tissue reconstruction following tumor removal or breast mastectomy surgery, the development of tissue-engineered cartilage or bone, and the treatment of cardiovascular disease.
"Abruptly discontinuing co-trimoxazole - an antibiotic used to prevent opportunistic infections in HIV-positive people - can lead to a higher incidence of malaria and diarrhea compared with patients who keep on taking the drug," according to a study conducted by the CDC in eastern Uganda and published by the Oxford Journal of Clinical Infectious Diseases in March, PlusNews reports.
Thoughtified Limited, a SETsquared start-up company created by graduates of the Department of Computing, University of Surrey has won a major grant from the Technology Strategy Board. The grant will enable the Surrey Research Park-based company to work in the development of a participatory sensing system that will improve the management of NHS patient records in remote patient treatment. The web and smartphone hybrid system will enable significant cost savings for the NHS, through improved utilisation of resources and reducing the inefficiencies that are typically incurred in the treatment of patients at home. The total finance raised for the project amounts to £94,000.
FGX International Holdings Limited today announced that it has signed a definitive agreement to merge with a subsidiary of Essilor International of Charenton-le-Pont, France. Essilor shares trade on the NYSE Euronext Paris market and are included in the CAC 40 index.
› Verified 7 days ago
| Entity Name | Ellis Bandt Birkin Kollins & Wong Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1578584678 PECOS PAC ID: 4486568946 Enrollment ID: O20031118000697 |
News Archive
Teva Pharmaceutical Industries Ltd. and Active Biotech today presented data further illuminating the novel, dual mechanism of action (MOA) of investigational oral, once-daily, laquinimod for the treatment of relapsing-remitting multiple sclerosis (RRMS), conferring neuroprotective and anti-inflammatory properties.
Stem cells extracted from body fat may pave the way for the development of new regenerative therapies including soft tissue reconstruction following tumor removal or breast mastectomy surgery, the development of tissue-engineered cartilage or bone, and the treatment of cardiovascular disease.
"Abruptly discontinuing co-trimoxazole - an antibiotic used to prevent opportunistic infections in HIV-positive people - can lead to a higher incidence of malaria and diarrhea compared with patients who keep on taking the drug," according to a study conducted by the CDC in eastern Uganda and published by the Oxford Journal of Clinical Infectious Diseases in March, PlusNews reports.
Thoughtified Limited, a SETsquared start-up company created by graduates of the Department of Computing, University of Surrey has won a major grant from the Technology Strategy Board. The grant will enable the Surrey Research Park-based company to work in the development of a participatory sensing system that will improve the management of NHS patient records in remote patient treatment. The web and smartphone hybrid system will enable significant cost savings for the NHS, through improved utilisation of resources and reducing the inefficiencies that are typically incurred in the treatment of patients at home. The total finance raised for the project amounts to £94,000.
FGX International Holdings Limited today announced that it has signed a definitive agreement to merge with a subsidiary of Essilor International of Charenton-le-Pont, France. Essilor shares trade on the NYSE Euronext Paris market and are included in the CAC 40 index.
› Verified 7 days ago
| Entity Name | Southwest Medical Associates Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1659346005 PECOS PAC ID: 6103730544 Enrollment ID: O20031118001102 |
News Archive
Teva Pharmaceutical Industries Ltd. and Active Biotech today presented data further illuminating the novel, dual mechanism of action (MOA) of investigational oral, once-daily, laquinimod for the treatment of relapsing-remitting multiple sclerosis (RRMS), conferring neuroprotective and anti-inflammatory properties.
Stem cells extracted from body fat may pave the way for the development of new regenerative therapies including soft tissue reconstruction following tumor removal or breast mastectomy surgery, the development of tissue-engineered cartilage or bone, and the treatment of cardiovascular disease.
"Abruptly discontinuing co-trimoxazole - an antibiotic used to prevent opportunistic infections in HIV-positive people - can lead to a higher incidence of malaria and diarrhea compared with patients who keep on taking the drug," according to a study conducted by the CDC in eastern Uganda and published by the Oxford Journal of Clinical Infectious Diseases in March, PlusNews reports.
Thoughtified Limited, a SETsquared start-up company created by graduates of the Department of Computing, University of Surrey has won a major grant from the Technology Strategy Board. The grant will enable the Surrey Research Park-based company to work in the development of a participatory sensing system that will improve the management of NHS patient records in remote patient treatment. The web and smartphone hybrid system will enable significant cost savings for the NHS, through improved utilisation of resources and reducing the inefficiencies that are typically incurred in the treatment of patients at home. The total finance raised for the project amounts to £94,000.
FGX International Holdings Limited today announced that it has signed a definitive agreement to merge with a subsidiary of Essilor International of Charenton-le-Pont, France. Essilor shares trade on the NYSE Euronext Paris market and are included in the CAC 40 index.
› Verified 7 days ago
| Entity Name | Optum Medical Group Ii Rhodes P C |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1770556037 PECOS PAC ID: 4981687779 Enrollment ID: O20040611000770 |
News Archive
Teva Pharmaceutical Industries Ltd. and Active Biotech today presented data further illuminating the novel, dual mechanism of action (MOA) of investigational oral, once-daily, laquinimod for the treatment of relapsing-remitting multiple sclerosis (RRMS), conferring neuroprotective and anti-inflammatory properties.
Stem cells extracted from body fat may pave the way for the development of new regenerative therapies including soft tissue reconstruction following tumor removal or breast mastectomy surgery, the development of tissue-engineered cartilage or bone, and the treatment of cardiovascular disease.
"Abruptly discontinuing co-trimoxazole - an antibiotic used to prevent opportunistic infections in HIV-positive people - can lead to a higher incidence of malaria and diarrhea compared with patients who keep on taking the drug," according to a study conducted by the CDC in eastern Uganda and published by the Oxford Journal of Clinical Infectious Diseases in March, PlusNews reports.
Thoughtified Limited, a SETsquared start-up company created by graduates of the Department of Computing, University of Surrey has won a major grant from the Technology Strategy Board. The grant will enable the Surrey Research Park-based company to work in the development of a participatory sensing system that will improve the management of NHS patient records in remote patient treatment. The web and smartphone hybrid system will enable significant cost savings for the NHS, through improved utilisation of resources and reducing the inefficiencies that are typically incurred in the treatment of patients at home. The total finance raised for the project amounts to £94,000.
FGX International Holdings Limited today announced that it has signed a definitive agreement to merge with a subsidiary of Essilor International of Charenton-le-Pont, France. Essilor shares trade on the NYSE Euronext Paris market and are included in the CAC 40 index.
› Verified 7 days ago
| Entity Name | Shelin Agrawal And Hyer Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1861783961 PECOS PAC ID: 5890955959 Enrollment ID: O20120327000625 |
News Archive
Teva Pharmaceutical Industries Ltd. and Active Biotech today presented data further illuminating the novel, dual mechanism of action (MOA) of investigational oral, once-daily, laquinimod for the treatment of relapsing-remitting multiple sclerosis (RRMS), conferring neuroprotective and anti-inflammatory properties.
Stem cells extracted from body fat may pave the way for the development of new regenerative therapies including soft tissue reconstruction following tumor removal or breast mastectomy surgery, the development of tissue-engineered cartilage or bone, and the treatment of cardiovascular disease.
"Abruptly discontinuing co-trimoxazole - an antibiotic used to prevent opportunistic infections in HIV-positive people - can lead to a higher incidence of malaria and diarrhea compared with patients who keep on taking the drug," according to a study conducted by the CDC in eastern Uganda and published by the Oxford Journal of Clinical Infectious Diseases in March, PlusNews reports.
Thoughtified Limited, a SETsquared start-up company created by graduates of the Department of Computing, University of Surrey has won a major grant from the Technology Strategy Board. The grant will enable the Surrey Research Park-based company to work in the development of a participatory sensing system that will improve the management of NHS patient records in remote patient treatment. The web and smartphone hybrid system will enable significant cost savings for the NHS, through improved utilisation of resources and reducing the inefficiencies that are typically incurred in the treatment of patients at home. The total finance raised for the project amounts to £94,000.
FGX International Holdings Limited today announced that it has signed a definitive agreement to merge with a subsidiary of Essilor International of Charenton-le-Pont, France. Essilor shares trade on the NYSE Euronext Paris market and are included in the CAC 40 index.
› Verified 7 days ago
| Entity Name | Triad Radiology Associates Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1659485001 PECOS PAC ID: 8729086194 Enrollment ID: O20230919001037 |
News Archive
Teva Pharmaceutical Industries Ltd. and Active Biotech today presented data further illuminating the novel, dual mechanism of action (MOA) of investigational oral, once-daily, laquinimod for the treatment of relapsing-remitting multiple sclerosis (RRMS), conferring neuroprotective and anti-inflammatory properties.
Stem cells extracted from body fat may pave the way for the development of new regenerative therapies including soft tissue reconstruction following tumor removal or breast mastectomy surgery, the development of tissue-engineered cartilage or bone, and the treatment of cardiovascular disease.
"Abruptly discontinuing co-trimoxazole - an antibiotic used to prevent opportunistic infections in HIV-positive people - can lead to a higher incidence of malaria and diarrhea compared with patients who keep on taking the drug," according to a study conducted by the CDC in eastern Uganda and published by the Oxford Journal of Clinical Infectious Diseases in March, PlusNews reports.
Thoughtified Limited, a SETsquared start-up company created by graduates of the Department of Computing, University of Surrey has won a major grant from the Technology Strategy Board. The grant will enable the Surrey Research Park-based company to work in the development of a participatory sensing system that will improve the management of NHS patient records in remote patient treatment. The web and smartphone hybrid system will enable significant cost savings for the NHS, through improved utilisation of resources and reducing the inefficiencies that are typically incurred in the treatment of patients at home. The total finance raised for the project amounts to £94,000.
FGX International Holdings Limited today announced that it has signed a definitive agreement to merge with a subsidiary of Essilor International of Charenton-le-Pont, France. Essilor shares trade on the NYSE Euronext Paris market and are included in the CAC 40 index.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Dina Robin Gabaeff, MD 2020 Palomino Lane, #100, Las Vegas, NV 89106-4894 Ph: (702) 759-8600 | Dr Dina Robin Gabaeff, MD 2020 Palomino Lane, #100, Las Vegas, NV 89106-4894 Ph: (702) 759-8600 |
News Archive
Teva Pharmaceutical Industries Ltd. and Active Biotech today presented data further illuminating the novel, dual mechanism of action (MOA) of investigational oral, once-daily, laquinimod for the treatment of relapsing-remitting multiple sclerosis (RRMS), conferring neuroprotective and anti-inflammatory properties.
Stem cells extracted from body fat may pave the way for the development of new regenerative therapies including soft tissue reconstruction following tumor removal or breast mastectomy surgery, the development of tissue-engineered cartilage or bone, and the treatment of cardiovascular disease.
"Abruptly discontinuing co-trimoxazole - an antibiotic used to prevent opportunistic infections in HIV-positive people - can lead to a higher incidence of malaria and diarrhea compared with patients who keep on taking the drug," according to a study conducted by the CDC in eastern Uganda and published by the Oxford Journal of Clinical Infectious Diseases in March, PlusNews reports.
Thoughtified Limited, a SETsquared start-up company created by graduates of the Department of Computing, University of Surrey has won a major grant from the Technology Strategy Board. The grant will enable the Surrey Research Park-based company to work in the development of a participatory sensing system that will improve the management of NHS patient records in remote patient treatment. The web and smartphone hybrid system will enable significant cost savings for the NHS, through improved utilisation of resources and reducing the inefficiencies that are typically incurred in the treatment of patients at home. The total finance raised for the project amounts to £94,000.
FGX International Holdings Limited today announced that it has signed a definitive agreement to merge with a subsidiary of Essilor International of Charenton-le-Pont, France. Essilor shares trade on the NYSE Euronext Paris market and are included in the CAC 40 index.
› Verified 7 days ago
Dr. Douglas Glen Larson, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 2020 Palomino Ln, #100, Las Vegas, NV 89106 Phone: 702-759-8600 | |
Saravanan Valliappan, MD Radiology Medicare: Accepting Medicare Assignments Practice Location: 5495 S Rainbow Blvd Ste 101, Las Vegas, NV 89118 Phone: 702-477-0772 | |
Ho Viet Nguyen, MD Radiology Medicare: Accepting Medicare Assignments Practice Location: 2950 S Maryland Pkwy, Las Vegas, NV 89109 Phone: 702-240-1215 Fax: 702-243-7531 | |
Gorden Chu, MD Radiology Medicare: Not Enrolled in Medicare Practice Location: 2950 S Maryland Pkwy, Las Vegas, NV 89109 Phone: 702-732-6000 Fax: 702-243-7531 | |
Nader Beheshti, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 5495 S Rainbow Blvd Ste 101, Las Vegas, NV 89118 Phone: 702-477-0772 | |
Joshua Rosenberg, DO Radiology Medicare: Accepting Medicare Assignments Practice Location: 2020 Palomino Lane, Ste # 100, Las Vegas, NV 89106 Phone: 702-759-8600 Fax: 702-384-1815 | |
Skyler Wayne Greene, MD Radiology Medicare: Accepting Medicare Assignments Practice Location: 2950 S Maryland Pkwy, Las Vegas, NV 89109 Phone: 702-732-6000 |